EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence–augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T

Laura De Michieli, Jonathan D Knott, Zachi I Attia iD, Olatunde Ola, Ramila A Mehta, Ashok Akula, David O Hodge, Rajiv Gulati, Paul A Friedman iD, Allan S Jaffe, Yader Sandoval iD

European Heart Journal. Acute Cardiovascular Care · 2023

DOI: 10.1093/ehjacc/zuac156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal. Acute Cardiovascular Care, 2023. Verfasst von Laura De Michieli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Troponin T, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Our goal was to evaluate a previously validated artificial intelligence–augmented electrocardiography (AI-ECG) screening tool for left ventricular systolic dysfunction (LVSD) in patients undergoing high-sensitivity-cardiac troponin T (hs-cTnT). Methods and results Retrospective application of AI-ECG for LVSD in emergency department (ED) patients undergoing hs-cTnT. AI-ECG scores (0–1) for probability of LVSD (left ventricular ejection fraction ≤ 35%) were obtained. An AI-ECG score ≥0.256 indicates a positive screen. The primary endpoint was a composite of post-discharge major adverse cardiovascular events (MACEs) at two years follow-up. Among 1977 patients, 248 (13%) had a positive AI-ECG. When compared with patients with a negative AI-ECG, those with a positive AI-ECG had a higher risk for MACE [48 vs. 21%, P < 0.0001, adjusted hazard ratio (HR) 1.39, 95% confidence interval (CI) 1.11–1.75]. This was largely because of a higher rate of deaths (32 vs. 14%, P < 0.0001; adjusted HR 1.26, 95% 0.95–1.66) and heart failure hospitalizations (26 vs. 6.1%, P < 0.001; adjusted HR 1.75, 95% CI 1.25–2.45). Together, hs-cTnT and AI-ECG resulted in the following MACE rates and adjusted HRs: hs-cTnT < 99th percentile and negative AI-ECG: 116/1176 (11%; reference), hs-cTnT < 99th percentile and positive AI-ECG: 28/107 (26%; adjusted HR 1.54, 95% CI 1.01–2.36), hs-cTnT > 99th percentile and negative AI-ECG: 233/553 (42%; adjusted HR 2.12, 95% CI 1.66, 2.70), and hs-cTnT > 99th percentile and positive AI-ECG: 91/141 (65%; adjusted HR 2.83, 95% CI 2.06, 3.87).

Conclusion

Among ED patients evaluated with hs-cTnT, a positive AI-ECG for LVSD identifies patients at high risk for MACE. The conjoint use of hs-cTnT and AI-ECG facilitates risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin TVentricular Dysfunction, LeftHumansArtificial IntelligenceRetrospective StudiesStroke VolumeAftercareVentricular Function, LeftPatient DischargeElectrocardiographyBiomarkers

Stichwörter der Autor:innen

Artificial intelligenceElectrocardiogramHigh-sensitivity-cardiac troponinMyocardial infarctionMyocardial injury

Substanzen

Troponin TBiomarkers

Autor:innen und Institutionen

  • Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
  • Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
  • Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Hospital Internal Medicine, Mayo Clinic Health System, La Crosse, WI, USA.
  • Center for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Rochester MN, USA.
  • Department of Quantitative Health Sciences, Mayo College of Medicine, Rochester, MN, USA.

ORCID-Profile: Zachi I Attia, Paul A Friedman, Yader Sandoval

Zitieren

APA

De Michieli, L., Knott, J. D., Attia, Z. I., Ola, O., Mehta, R. A., Akula, A., Hodge, D. O., Gulati, R., Friedman, P. A., Jaffe, A. S., & Sandoval, Y. (2023). Artificial intelligence–augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T. European Heart Journal. Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuac156

Vancouver

De Michieli L, Knott JD, Attia ZI, Ola O, Mehta RA, Akula A, et al. Artificial intelligence–augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T. European Heart Journal. Acute Cardiovascular Care. 2023. doi:10.1093/ehjacc/zuac156

BibTeX
@article{DeMichieli2023,
  author = {De Michieli, Laura and Knott, Jonathan D and Attia, Zachi I and Ola, Olatunde and Mehta, Ramila A and Akula, Ashok and Hodge, David O and Gulati, Rajiv and Friedman, Paul A and Jaffe, Allan S and Sandoval, Yader},
  title = {Artificial intelligence–augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T},
  journal = {European Heart Journal. Acute Cardiovascular Care},
  year = {2023},
  doi = {10.1093/ehjacc/zuac156}
}
Kostenlos starten →